nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—RBP1—prostate gland—urinary bladder cancer	0.012	0.0695	CbGeAlD
Acitretin—RARB—prostate gland—urinary bladder cancer	0.0111	0.0643	CbGeAlD
Acitretin—CYP26A1—female reproductive system—urinary bladder cancer	0.0109	0.0635	CbGeAlD
Acitretin—RXRG—prostate gland—urinary bladder cancer	0.0108	0.0629	CbGeAlD
Acitretin—RARG—prostate gland—urinary bladder cancer	0.00904	0.0525	CbGeAlD
Acitretin—RBP1—epithelium—urinary bladder cancer	0.0088	0.0511	CbGeAlD
Acitretin—RARA—prostate gland—urinary bladder cancer	0.0085	0.0493	CbGeAlD
Acitretin—RBP1—smooth muscle tissue—urinary bladder cancer	0.00848	0.0492	CbGeAlD
Acitretin—RXRA—renal system—urinary bladder cancer	0.00841	0.0488	CbGeAlD
Acitretin—RBP1—renal system—urinary bladder cancer	0.00816	0.0474	CbGeAlD
Acitretin—RXRA—female reproductive system—urinary bladder cancer	0.00673	0.0391	CbGeAlD
Acitretin—RBP1—female reproductive system—urinary bladder cancer	0.00654	0.0379	CbGeAlD
Acitretin—RARG—urethra—urinary bladder cancer	0.00605	0.0351	CbGeAlD
Acitretin—RARB—female reproductive system—urinary bladder cancer	0.00605	0.0351	CbGeAlD
Acitretin—RBP1—vagina—urinary bladder cancer	0.00591	0.0343	CbGeAlD
Acitretin—RARA—renal system—urinary bladder cancer	0.00579	0.0336	CbGeAlD
Acitretin—RARB—vagina—urinary bladder cancer	0.00547	0.0317	CbGeAlD
Acitretin—RXRB—vagina—urinary bladder cancer	0.00503	0.0292	CbGeAlD
Acitretin—RARG—female reproductive system—urinary bladder cancer	0.00493	0.0286	CbGeAlD
Acitretin—RARA—female reproductive system—urinary bladder cancer	0.00464	0.0269	CbGeAlD
Acitretin—RARG—vagina—urinary bladder cancer	0.00446	0.0259	CbGeAlD
Acitretin—RBP1—lymph node—urinary bladder cancer	0.00382	0.0222	CbGeAlD
Acitretin—RARB—lymph node—urinary bladder cancer	0.00354	0.0205	CbGeAlD
Acitretin—RARG—lymph node—urinary bladder cancer	0.00289	0.0168	CbGeAlD
Acitretin—RARA—lymph node—urinary bladder cancer	0.00271	0.0157	CbGeAlD
Acitretin—ALB—lymph node—urinary bladder cancer	0.00153	0.00888	CbGeAlD
Acitretin—Paraesthesia—Etoposide—urinary bladder cancer	0.000293	0.000627	CcSEcCtD
Acitretin—Weight increased—Epirubicin—urinary bladder cancer	0.000293	0.000627	CcSEcCtD
Acitretin—Haematuria—Methotrexate—urinary bladder cancer	0.000292	0.000625	CcSEcCtD
Acitretin—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000292	0.000625	CcSEcCtD
Acitretin—Weight decreased—Epirubicin—urinary bladder cancer	0.000291	0.000623	CcSEcCtD
Acitretin—Somnolence—Etoposide—urinary bladder cancer	0.00029	0.000621	CcSEcCtD
Acitretin—Epistaxis—Methotrexate—urinary bladder cancer	0.000289	0.000619	CcSEcCtD
Acitretin—Vomiting—Thiotepa—urinary bladder cancer	0.000289	0.000618	CcSEcCtD
Acitretin—Rash—Thiotepa—urinary bladder cancer	0.000287	0.000613	CcSEcCtD
Acitretin—Dermatitis—Thiotepa—urinary bladder cancer	0.000286	0.000612	CcSEcCtD
Acitretin—Headache—Thiotepa—urinary bladder cancer	0.000285	0.000609	CcSEcCtD
Acitretin—Decreased appetite—Etoposide—urinary bladder cancer	0.000284	0.000607	CcSEcCtD
Acitretin—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000283	0.000605	CcSEcCtD
Acitretin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000282	0.000603	CcSEcCtD
Acitretin—Body temperature increased—Cisplatin—urinary bladder cancer	0.000282	0.000603	CcSEcCtD
Acitretin—Fatigue—Etoposide—urinary bladder cancer	0.000282	0.000602	CcSEcCtD
Acitretin—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000281	0.000602	CcSEcCtD
Acitretin—Stomatitis—Epirubicin—urinary bladder cancer	0.00028	0.000598	CcSEcCtD
Acitretin—Jaundice—Epirubicin—urinary bladder cancer	0.00028	0.000598	CcSEcCtD
Acitretin—Constipation—Etoposide—urinary bladder cancer	0.000279	0.000597	CcSEcCtD
Acitretin—Pain—Etoposide—urinary bladder cancer	0.000279	0.000597	CcSEcCtD
Acitretin—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000279	0.000597	CcSEcCtD
Acitretin—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000279	0.000597	CcSEcCtD
Acitretin—Dysuria—Doxorubicin—urinary bladder cancer	0.000278	0.000596	CcSEcCtD
Acitretin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000277	0.000592	CcSEcCtD
Acitretin—Haemoglobin—Methotrexate—urinary bladder cancer	0.000277	0.000592	CcSEcCtD
Acitretin—Haemorrhage—Methotrexate—urinary bladder cancer	0.000275	0.000589	CcSEcCtD
Acitretin—Hepatitis—Methotrexate—urinary bladder cancer	0.000275	0.000589	CcSEcCtD
Acitretin—Asthenia—Gemcitabine—urinary bladder cancer	0.000274	0.000587	CcSEcCtD
Acitretin—Haematuria—Epirubicin—urinary bladder cancer	0.000274	0.000585	CcSEcCtD
Acitretin—Pharyngitis—Methotrexate—urinary bladder cancer	0.000273	0.000584	CcSEcCtD
Acitretin—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000272	0.000581	CcSEcCtD
Acitretin—Weight increased—Doxorubicin—urinary bladder cancer	0.000271	0.00058	CcSEcCtD
Acitretin—Epistaxis—Epirubicin—urinary bladder cancer	0.000271	0.000579	CcSEcCtD
Acitretin—Pruritus—Gemcitabine—urinary bladder cancer	0.000271	0.000579	CcSEcCtD
Acitretin—Nausea—Thiotepa—urinary bladder cancer	0.00027	0.000578	CcSEcCtD
Acitretin—Weight decreased—Doxorubicin—urinary bladder cancer	0.000269	0.000576	CcSEcCtD
Acitretin—Sinusitis—Epirubicin—urinary bladder cancer	0.000269	0.000576	CcSEcCtD
Acitretin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000269	0.000576	CcSEcCtD
Acitretin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000267	0.000571	CcSEcCtD
Acitretin—Pruritus—Fluorouracil—urinary bladder cancer	0.000266	0.000569	CcSEcCtD
Acitretin—Visual impairment—Methotrexate—urinary bladder cancer	0.000265	0.000567	CcSEcCtD
Acitretin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000263	0.000562	CcSEcCtD
Acitretin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000262	0.00056	CcSEcCtD
Acitretin—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.00026	0.000557	CcSEcCtD
Acitretin—Urticaria—Etoposide—urinary bladder cancer	0.000259	0.000555	CcSEcCtD
Acitretin—Haemoglobin—Epirubicin—urinary bladder cancer	0.000259	0.000554	CcSEcCtD
Acitretin—Jaundice—Doxorubicin—urinary bladder cancer	0.000259	0.000554	CcSEcCtD
Acitretin—Stomatitis—Doxorubicin—urinary bladder cancer	0.000259	0.000554	CcSEcCtD
Acitretin—Rhinitis—Epirubicin—urinary bladder cancer	0.000258	0.000552	CcSEcCtD
Acitretin—Abdominal pain—Etoposide—urinary bladder cancer	0.000258	0.000552	CcSEcCtD
Acitretin—Body temperature increased—Etoposide—urinary bladder cancer	0.000258	0.000552	CcSEcCtD
Acitretin—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000258	0.000552	CcSEcCtD
Acitretin—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000258	0.000552	CcSEcCtD
Acitretin—Haemorrhage—Epirubicin—urinary bladder cancer	0.000258	0.000551	CcSEcCtD
Acitretin—Hepatitis—Epirubicin—urinary bladder cancer	0.000258	0.000551	CcSEcCtD
Acitretin—Eye disorder—Methotrexate—urinary bladder cancer	0.000257	0.00055	CcSEcCtD
Acitretin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000257	0.00055	CcSEcCtD
Acitretin—Tinnitus—Methotrexate—urinary bladder cancer	0.000257	0.000549	CcSEcCtD
Acitretin—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000256	0.000548	CcSEcCtD
Acitretin—Asthenia—Cisplatin—urinary bladder cancer	0.000256	0.000547	CcSEcCtD
Acitretin—Pharyngitis—Epirubicin—urinary bladder cancer	0.000256	0.000547	CcSEcCtD
Acitretin—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000254	0.000543	CcSEcCtD
Acitretin—Haematuria—Doxorubicin—urinary bladder cancer	0.000253	0.000542	CcSEcCtD
Acitretin—Epistaxis—Doxorubicin—urinary bladder cancer	0.00025	0.000536	CcSEcCtD
Acitretin—Angiopathy—Methotrexate—urinary bladder cancer	0.00025	0.000534	CcSEcCtD
Acitretin—Sinusitis—Doxorubicin—urinary bladder cancer	0.000249	0.000533	CcSEcCtD
Acitretin—Immune system disorder—Methotrexate—urinary bladder cancer	0.000249	0.000532	CcSEcCtD
Acitretin—Dizziness—Fluorouracil—urinary bladder cancer	0.000249	0.000532	CcSEcCtD
Acitretin—Visual impairment—Epirubicin—urinary bladder cancer	0.000248	0.000531	CcSEcCtD
Acitretin—Chills—Methotrexate—urinary bladder cancer	0.000247	0.000528	CcSEcCtD
Acitretin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000244	0.000522	CcSEcCtD
Acitretin—Alopecia—Methotrexate—urinary bladder cancer	0.000243	0.00052	CcSEcCtD
Acitretin—Vomiting—Gemcitabine—urinary bladder cancer	0.000243	0.00052	CcSEcCtD
Acitretin—Rash—Gemcitabine—urinary bladder cancer	0.000241	0.000516	CcSEcCtD
Acitretin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000241	0.000515	CcSEcCtD
Acitretin—Eye disorder—Epirubicin—urinary bladder cancer	0.000241	0.000515	CcSEcCtD
Acitretin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000241	0.000515	CcSEcCtD
Acitretin—Tinnitus—Epirubicin—urinary bladder cancer	0.00024	0.000514	CcSEcCtD
Acitretin—Erythema—Methotrexate—urinary bladder cancer	0.00024	0.000513	CcSEcCtD
Acitretin—Haemoglobin—Doxorubicin—urinary bladder cancer	0.00024	0.000512	CcSEcCtD
Acitretin—Headache—Gemcitabine—urinary bladder cancer	0.00024	0.000512	CcSEcCtD
Acitretin—Flushing—Epirubicin—urinary bladder cancer	0.000239	0.000511	CcSEcCtD
Acitretin—Vomiting—Fluorouracil—urinary bladder cancer	0.000239	0.000511	CcSEcCtD
Acitretin—Rhinitis—Doxorubicin—urinary bladder cancer	0.000239	0.000511	CcSEcCtD
Acitretin—Hepatitis—Doxorubicin—urinary bladder cancer	0.000238	0.00051	CcSEcCtD
Acitretin—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000238	0.00051	CcSEcCtD
Acitretin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000237	0.000507	CcSEcCtD
Acitretin—Rash—Fluorouracil—urinary bladder cancer	0.000237	0.000507	CcSEcCtD
Acitretin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000237	0.000507	CcSEcCtD
Acitretin—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000237	0.000506	CcSEcCtD
Acitretin—Headache—Fluorouracil—urinary bladder cancer	0.000236	0.000504	CcSEcCtD
Acitretin—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000235	0.000502	CcSEcCtD
Acitretin—Dysgeusia—Methotrexate—urinary bladder cancer	0.000235	0.000502	CcSEcCtD
Acitretin—Asthenia—Etoposide—urinary bladder cancer	0.000234	0.000501	CcSEcCtD
Acitretin—Angiopathy—Epirubicin—urinary bladder cancer	0.000234	0.0005	CcSEcCtD
Acitretin—Immune system disorder—Epirubicin—urinary bladder cancer	0.000233	0.000498	CcSEcCtD
Acitretin—Back pain—Methotrexate—urinary bladder cancer	0.000232	0.000496	CcSEcCtD
Acitretin—Chills—Epirubicin—urinary bladder cancer	0.000231	0.000494	CcSEcCtD
Acitretin—Pruritus—Etoposide—urinary bladder cancer	0.000231	0.000494	CcSEcCtD
Acitretin—Visual impairment—Doxorubicin—urinary bladder cancer	0.00023	0.000491	CcSEcCtD
Acitretin—Alopecia—Epirubicin—urinary bladder cancer	0.000228	0.000487	CcSEcCtD
Acitretin—Nausea—Gemcitabine—urinary bladder cancer	0.000227	0.000486	CcSEcCtD
Acitretin—Vomiting—Cisplatin—urinary bladder cancer	0.000227	0.000485	CcSEcCtD
Acitretin—Vision blurred—Methotrexate—urinary bladder cancer	0.000226	0.000483	CcSEcCtD
Acitretin—Rash—Cisplatin—urinary bladder cancer	0.000225	0.000481	CcSEcCtD
Acitretin—Dermatitis—Cisplatin—urinary bladder cancer	0.000225	0.00048	CcSEcCtD
Acitretin—Erythema—Epirubicin—urinary bladder cancer	0.000224	0.00048	CcSEcCtD
Acitretin—Diarrhoea—Etoposide—urinary bladder cancer	0.000223	0.000478	CcSEcCtD
Acitretin—Nausea—Fluorouracil—urinary bladder cancer	0.000223	0.000478	CcSEcCtD
Acitretin—Eye disorder—Doxorubicin—urinary bladder cancer	0.000223	0.000476	CcSEcCtD
Acitretin—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000222	0.000476	CcSEcCtD
Acitretin—Tinnitus—Doxorubicin—urinary bladder cancer	0.000222	0.000475	CcSEcCtD
Acitretin—Flushing—Doxorubicin—urinary bladder cancer	0.000221	0.000473	CcSEcCtD
Acitretin—Tension—Epirubicin—urinary bladder cancer	0.00022	0.000471	CcSEcCtD
Acitretin—Dysgeusia—Epirubicin—urinary bladder cancer	0.00022	0.00047	CcSEcCtD
Acitretin—Nervousness—Epirubicin—urinary bladder cancer	0.000218	0.000466	CcSEcCtD
Acitretin—Back pain—Epirubicin—urinary bladder cancer	0.000217	0.000464	CcSEcCtD
Acitretin—Angiopathy—Doxorubicin—urinary bladder cancer	0.000216	0.000463	CcSEcCtD
Acitretin—Malaise—Methotrexate—urinary bladder cancer	0.000216	0.000462	CcSEcCtD
Acitretin—Dizziness—Etoposide—urinary bladder cancer	0.000216	0.000462	CcSEcCtD
Acitretin—Muscle spasms—Epirubicin—urinary bladder cancer	0.000216	0.000461	CcSEcCtD
Acitretin—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000215	0.000461	CcSEcCtD
Acitretin—Chills—Doxorubicin—urinary bladder cancer	0.000214	0.000457	CcSEcCtD
Acitretin—Nausea—Cisplatin—urinary bladder cancer	0.000212	0.000453	CcSEcCtD
Acitretin—Vision blurred—Epirubicin—urinary bladder cancer	0.000211	0.000452	CcSEcCtD
Acitretin—Alopecia—Doxorubicin—urinary bladder cancer	0.000211	0.000451	CcSEcCtD
Acitretin—RXRA—Metabolism—GSTZ1—urinary bladder cancer	0.000209	0.000581	CbGpPWpGaD
Acitretin—Cough—Methotrexate—urinary bladder cancer	0.000209	0.000447	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	0.000209	0.000581	CbGpPWpGaD
Acitretin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—urinary bladder cancer	0.000208	0.000579	CbGpPWpGaD
Acitretin—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000208	0.000445	CcSEcCtD
Acitretin—Vomiting—Etoposide—urinary bladder cancer	0.000208	0.000444	CcSEcCtD
Acitretin—Erythema—Doxorubicin—urinary bladder cancer	0.000208	0.000444	CcSEcCtD
Acitretin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—urinary bladder cancer	0.000206	0.000572	CbGpPWpGaD
Acitretin—Rash—Etoposide—urinary bladder cancer	0.000206	0.00044	CcSEcCtD
Acitretin—Dermatitis—Etoposide—urinary bladder cancer	0.000206	0.00044	CcSEcCtD
Acitretin—RARB—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000206	0.000571	CbGpPWpGaD
Acitretin—RARB—Gene Expression—SMC1A—urinary bladder cancer	0.000205	0.00057	CbGpPWpGaD
Acitretin—Headache—Etoposide—urinary bladder cancer	0.000205	0.000438	CcSEcCtD
Acitretin—Chest pain—Methotrexate—urinary bladder cancer	0.000204	0.000436	CcSEcCtD
Acitretin—Myalgia—Methotrexate—urinary bladder cancer	0.000204	0.000436	CcSEcCtD
Acitretin—Arthralgia—Methotrexate—urinary bladder cancer	0.000204	0.000436	CcSEcCtD
Acitretin—Tension—Doxorubicin—urinary bladder cancer	0.000204	0.000436	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—JAG1—urinary bladder cancer	0.000204	0.000565	CbGpPWpGaD
Acitretin—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000203	0.000435	CcSEcCtD
Acitretin—Malaise—Epirubicin—urinary bladder cancer	0.000202	0.000433	CcSEcCtD
Acitretin—Discomfort—Methotrexate—urinary bladder cancer	0.000202	0.000431	CcSEcCtD
Acitretin—Nervousness—Doxorubicin—urinary bladder cancer	0.000202	0.000431	CcSEcCtD
Acitretin—RXRG—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000201	0.000559	CbGpPWpGaD
Acitretin—Back pain—Doxorubicin—urinary bladder cancer	0.000201	0.000429	CcSEcCtD
Acitretin—Muscle spasms—Doxorubicin—urinary bladder cancer	0.0002	0.000427	CcSEcCtD
Acitretin—RARG—Gene Expression—ESR2—urinary bladder cancer	0.0002	0.000554	CbGpPWpGaD
Acitretin—RBP1—Disease—ERCC2—urinary bladder cancer	0.000199	0.000553	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000199	0.000552	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTO2—urinary bladder cancer	0.000198	0.000551	CbGpPWpGaD
Acitretin—RXRA—Metabolism—NAT1—urinary bladder cancer	0.000198	0.000551	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000198	0.000549	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000197	0.000547	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000197	0.000547	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—SMC1A—urinary bladder cancer	0.000197	0.000547	CbGpPWpGaD
Acitretin—RARA—Gene Expression—SMC1A—urinary bladder cancer	0.000197	0.000547	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000196	0.000545	CbGpPWpGaD
Acitretin—Cough—Epirubicin—urinary bladder cancer	0.000196	0.000419	CcSEcCtD
Acitretin—Vision blurred—Doxorubicin—urinary bladder cancer	0.000196	0.000418	CcSEcCtD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000195	0.000542	CbGpPWpGaD
Acitretin—Infection—Methotrexate—urinary bladder cancer	0.000194	0.000416	CcSEcCtD
Acitretin—Nausea—Etoposide—urinary bladder cancer	0.000194	0.000415	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	0.000194	0.000538	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—CDKN1A—urinary bladder cancer	0.000193	0.000537	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000193	0.000536	CbGpPWpGaD
Acitretin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000193	0.000412	CcSEcCtD
Acitretin—Arthralgia—Epirubicin—urinary bladder cancer	0.000191	0.000408	CcSEcCtD
Acitretin—Chest pain—Epirubicin—urinary bladder cancer	0.000191	0.000408	CcSEcCtD
Acitretin—Myalgia—Epirubicin—urinary bladder cancer	0.000191	0.000408	CcSEcCtD
Acitretin—Anxiety—Epirubicin—urinary bladder cancer	0.00019	0.000407	CcSEcCtD
Acitretin—Skin disorder—Methotrexate—urinary bladder cancer	0.00019	0.000406	CcSEcCtD
Acitretin—RARA—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000189	0.000526	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000189	0.000526	CbGpPWpGaD
Acitretin—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000189	0.000404	CcSEcCtD
Acitretin—Discomfort—Epirubicin—urinary bladder cancer	0.000189	0.000403	CcSEcCtD
Acitretin—CYP26A1—Metabolism—NQO1—urinary bladder cancer	0.000189	0.000524	CbGpPWpGaD
Acitretin—Malaise—Doxorubicin—urinary bladder cancer	0.000187	0.0004	CcSEcCtD
Acitretin—RBP1—Disease—MTHFR—urinary bladder cancer	0.000187	0.00052	CbGpPWpGaD
Acitretin—Dry mouth—Epirubicin—urinary bladder cancer	0.000187	0.000399	CcSEcCtD
Acitretin—RBP1—Disease—TERT—urinary bladder cancer	0.000187	0.000518	CbGpPWpGaD
Acitretin—Anorexia—Methotrexate—urinary bladder cancer	0.000186	0.000399	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	0.000186	0.000516	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000186	0.000516	CbGpPWpGaD
Acitretin—Oedema—Epirubicin—urinary bladder cancer	0.000183	0.000391	CcSEcCtD
Acitretin—RXRG—Gene Expression—ESR2—urinary bladder cancer	0.000182	0.000507	CbGpPWpGaD
Acitretin—Infection—Epirubicin—urinary bladder cancer	0.000182	0.000389	CcSEcCtD
Acitretin—RXRA—Metabolism—UGT2B7—urinary bladder cancer	0.000181	0.000504	CbGpPWpGaD
Acitretin—Cough—Doxorubicin—urinary bladder cancer	0.000181	0.000387	CcSEcCtD
Acitretin—ALB—Platelet degranulation—IGF1—urinary bladder cancer	0.00018	0.000499	CbGpPWpGaD
Acitretin—RARB—Gene Expression—ESR2—urinary bladder cancer	0.000179	0.000497	CbGpPWpGaD
Acitretin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000178	0.000381	CcSEcCtD
Acitretin—Skin disorder—Epirubicin—urinary bladder cancer	0.000178	0.00038	CcSEcCtD
Acitretin—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000177	0.000378	CcSEcCtD
Acitretin—Insomnia—Methotrexate—urinary bladder cancer	0.000177	0.000378	CcSEcCtD
Acitretin—Myalgia—Doxorubicin—urinary bladder cancer	0.000177	0.000378	CcSEcCtD
Acitretin—Arthralgia—Doxorubicin—urinary bladder cancer	0.000177	0.000378	CcSEcCtD
Acitretin—Chest pain—Doxorubicin—urinary bladder cancer	0.000177	0.000378	CcSEcCtD
Acitretin—Anxiety—Doxorubicin—urinary bladder cancer	0.000176	0.000377	CcSEcCtD
Acitretin—Paraesthesia—Methotrexate—urinary bladder cancer	0.000176	0.000376	CcSEcCtD
Acitretin—Discomfort—Doxorubicin—urinary bladder cancer	0.000175	0.000373	CcSEcCtD
Acitretin—Anorexia—Epirubicin—urinary bladder cancer	0.000174	0.000373	CcSEcCtD
Acitretin—Somnolence—Methotrexate—urinary bladder cancer	0.000174	0.000372	CcSEcCtD
Acitretin—Dry mouth—Doxorubicin—urinary bladder cancer	0.000173	0.00037	CcSEcCtD
Acitretin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000172	0.000368	CcSEcCtD
Acitretin—RARA—Gene Expression—ESR2—urinary bladder cancer	0.000172	0.000476	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—ESR2—urinary bladder cancer	0.000172	0.000476	CbGpPWpGaD
Acitretin—RBP1—Disease—FGFR3—urinary bladder cancer	0.000171	0.000475	CbGpPWpGaD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	0.000171	0.000475	CbGpPWpGaD
Acitretin—Decreased appetite—Methotrexate—urinary bladder cancer	0.00017	0.000364	CcSEcCtD
Acitretin—Oedema—Doxorubicin—urinary bladder cancer	0.000169	0.000362	CcSEcCtD
Acitretin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000169	0.000361	CcSEcCtD
Acitretin—Fatigue—Methotrexate—urinary bladder cancer	0.000169	0.000361	CcSEcCtD
Acitretin—RXRA—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000169	0.000468	CbGpPWpGaD
Acitretin—Infection—Doxorubicin—urinary bladder cancer	0.000168	0.00036	CcSEcCtD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000167	0.000465	CbGpPWpGaD
Acitretin—Pain—Methotrexate—urinary bladder cancer	0.000167	0.000358	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000167	0.000357	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000166	0.000462	CbGpPWpGaD
Acitretin—Insomnia—Epirubicin—urinary bladder cancer	0.000166	0.000354	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—S100B—urinary bladder cancer	0.000165	0.000458	CbGpPWpGaD
Acitretin—Skin disorder—Doxorubicin—urinary bladder cancer	0.000165	0.000352	CcSEcCtD
Acitretin—Paraesthesia—Epirubicin—urinary bladder cancer	0.000164	0.000352	CcSEcCtD
Acitretin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000164	0.00035	CcSEcCtD
Acitretin—RXRA—Metabolism—CYP4B1—urinary bladder cancer	0.000163	0.000454	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.000163	0.000452	CbGpPWpGaD
Acitretin—Somnolence—Epirubicin—urinary bladder cancer	0.000163	0.000348	CcSEcCtD
Acitretin—Anorexia—Doxorubicin—urinary bladder cancer	0.000161	0.000345	CcSEcCtD
Acitretin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000161	0.000345	CcSEcCtD
Acitretin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000161	0.000345	CcSEcCtD
Acitretin—ALB—Folate Metabolism—IL2—urinary bladder cancer	0.000161	0.000447	CbGpPWpGaD
Acitretin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00016	0.000342	CcSEcCtD
Acitretin—Decreased appetite—Epirubicin—urinary bladder cancer	0.000159	0.00034	CcSEcCtD
Acitretin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000158	0.000338	CcSEcCtD
Acitretin—Fatigue—Epirubicin—urinary bladder cancer	0.000158	0.000338	CcSEcCtD
Acitretin—CYP26A1—Metabolism—GSTP1—urinary bladder cancer	0.000157	0.000437	CbGpPWpGaD
Acitretin—Pain—Epirubicin—urinary bladder cancer	0.000157	0.000335	CcSEcCtD
Acitretin—Constipation—Epirubicin—urinary bladder cancer	0.000157	0.000335	CcSEcCtD
Acitretin—Urticaria—Methotrexate—urinary bladder cancer	0.000155	0.000332	CcSEcCtD
Acitretin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000155	0.000331	CcSEcCtD
Acitretin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000155	0.000331	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000154	0.00033	CcSEcCtD
Acitretin—RXRA—Metabolism—SLC19A1—urinary bladder cancer	0.000154	0.000428	CbGpPWpGaD
Acitretin—RARG—Gene Expression—NCOR1—urinary bladder cancer	0.000154	0.000428	CbGpPWpGaD
Acitretin—Insomnia—Doxorubicin—urinary bladder cancer	0.000153	0.000328	CcSEcCtD
Acitretin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000152	0.000325	CcSEcCtD
Acitretin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000151	0.000323	CcSEcCtD
Acitretin—Somnolence—Doxorubicin—urinary bladder cancer	0.000151	0.000322	CcSEcCtD
Acitretin—RXRA—Metabolism—PRSS3—urinary bladder cancer	0.00015	0.000417	CbGpPWpGaD
Acitretin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00015	0.00032	CcSEcCtD
Acitretin—RXRA—Adipogenesis—TNF—urinary bladder cancer	0.000149	0.000415	CbGpPWpGaD
Acitretin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000149	0.000319	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—NCOR1—urinary bladder cancer	0.000148	0.000412	CbGpPWpGaD
Acitretin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000147	0.000315	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	0.000147	0.000408	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—TYMS—urinary bladder cancer	0.000146	0.000406	CbGpPWpGaD
Acitretin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000146	0.000313	CcSEcCtD
Acitretin—Fatigue—Doxorubicin—urinary bladder cancer	0.000146	0.000312	CcSEcCtD
Acitretin—RBP1—Disease—CREBBP—urinary bladder cancer	0.000146	0.000405	CbGpPWpGaD
Acitretin—Urticaria—Epirubicin—urinary bladder cancer	0.000145	0.000311	CcSEcCtD
Acitretin—Pain—Doxorubicin—urinary bladder cancer	0.000145	0.00031	CcSEcCtD
Acitretin—Constipation—Doxorubicin—urinary bladder cancer	0.000145	0.00031	CcSEcCtD
Acitretin—RARG—Gene Expression—ERCC2—urinary bladder cancer	0.000145	0.000402	CbGpPWpGaD
Acitretin—Body temperature increased—Epirubicin—urinary bladder cancer	0.000145	0.000309	CcSEcCtD
Acitretin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000145	0.000309	CcSEcCtD
Acitretin—CYP26A1—Metabolism—NCOR1—urinary bladder cancer	0.000145	0.000401	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—GSTM1—urinary bladder cancer	0.000145	0.000401	CbGpPWpGaD
Acitretin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000144	0.000308	CcSEcCtD
Acitretin—ALB—Vitamin B12 Metabolism—TNF—urinary bladder cancer	0.000144	0.0004	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000143	0.000398	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	0.000142	0.000395	CbGpPWpGaD
Acitretin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	0.000142	0.000394	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	0.000142	0.000394	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—NCOR1—urinary bladder cancer	0.000141	0.000391	CbGpPWpGaD
Acitretin—Asthenia—Methotrexate—urinary bladder cancer	0.00014	0.0003	CcSEcCtD
Acitretin—ALB—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.00014	0.000388	CbGpPWpGaD
Acitretin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00014	0.000298	CcSEcCtD
Acitretin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000138	0.000296	CcSEcCtD
Acitretin—CYP26A1—Metabolism—GPX1—urinary bladder cancer	0.000138	0.000384	CbGpPWpGaD
Acitretin—Pruritus—Methotrexate—urinary bladder cancer	0.000138	0.000296	CcSEcCtD
Acitretin—RARB—Gene Expression—NCOR1—urinary bladder cancer	0.000138	0.000384	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000138	0.000383	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—ERCC2—urinary bladder cancer	0.000136	0.000377	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	0.000135	0.000376	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—NCOR1—urinary bladder cancer	0.000135	0.000375	CbGpPWpGaD
Acitretin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000135	0.000288	CcSEcCtD
Acitretin—Urticaria—Doxorubicin—urinary bladder cancer	0.000135	0.000288	CcSEcCtD
Acitretin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000134	0.000286	CcSEcCtD
Acitretin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000134	0.000286	CcSEcCtD
Acitretin—Diarrhoea—Methotrexate—urinary bladder cancer	0.000134	0.000286	CcSEcCtD
Acitretin—RXRB—Gene Expression—NCOR1—urinary bladder cancer	0.000132	0.000368	CbGpPWpGaD
Acitretin—RARA—Gene Expression—NCOR1—urinary bladder cancer	0.000132	0.000368	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—ERCC2—urinary bladder cancer	0.000132	0.000368	CbGpPWpGaD
Acitretin—RBP1—Disease—RHOA—urinary bladder cancer	0.000132	0.000366	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	0.000132	0.000365	CbGpPWpGaD
Acitretin—Asthenia—Epirubicin—urinary bladder cancer	0.000131	0.000281	CcSEcCtD
Acitretin—RARG—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000131	0.000363	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TERT—urinary bladder cancer	0.000131	0.000363	CbGpPWpGaD
Acitretin—RARB—Gene Expression—ERCC2—urinary bladder cancer	0.00013	0.000361	CbGpPWpGaD
Acitretin—Pruritus—Epirubicin—urinary bladder cancer	0.000129	0.000277	CcSEcCtD
Acitretin—Dizziness—Methotrexate—urinary bladder cancer	0.000129	0.000277	CcSEcCtD
Acitretin—CYP26A1—Metabolism—MTHFR—urinary bladder cancer	0.000128	0.000355	CbGpPWpGaD
Acitretin—Diarrhoea—Epirubicin—urinary bladder cancer	0.000125	0.000268	CcSEcCtD
Acitretin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000125	0.000267	CcSEcCtD
Acitretin—RARA—Gene Expression—ERCC2—urinary bladder cancer	0.000125	0.000346	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—ERCC2—urinary bladder cancer	0.000125	0.000346	CbGpPWpGaD
Acitretin—Vomiting—Methotrexate—urinary bladder cancer	0.000124	0.000266	CcSEcCtD
Acitretin—Rash—Methotrexate—urinary bladder cancer	0.000123	0.000264	CcSEcCtD
Acitretin—Dermatitis—Methotrexate—urinary bladder cancer	0.000123	0.000264	CcSEcCtD
Acitretin—Headache—Methotrexate—urinary bladder cancer	0.000123	0.000262	CcSEcCtD
Acitretin—RBP1—Disease—ERBB2—urinary bladder cancer	0.000122	0.000339	CbGpPWpGaD
Acitretin—Asthenia—Doxorubicin—urinary bladder cancer	0.000122	0.00026	CcSEcCtD
Acitretin—Dizziness—Epirubicin—urinary bladder cancer	0.000121	0.000259	CcSEcCtD
Acitretin—RARG—Gene Expression—ESR1—urinary bladder cancer	0.000121	0.000336	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000121	0.000335	CbGpPWpGaD
Acitretin—RXRA—Metabolism—TYMP—urinary bladder cancer	0.00012	0.000334	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—FGFR3—urinary bladder cancer	0.00012	0.000333	CbGpPWpGaD
Acitretin—Pruritus—Doxorubicin—urinary bladder cancer	0.00012	0.000256	CcSEcCtD
Acitretin—RXRG—Generic Transcription Pathway—MYC—urinary bladder cancer	0.00012	0.000332	CbGpPWpGaD
Acitretin—RBP1—Disease—PTGS2—urinary bladder cancer	0.000119	0.000331	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	0.000118	0.000327	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000117	0.000326	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TNF—urinary bladder cancer	0.000117	0.000326	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—ESR1—urinary bladder cancer	0.000116	0.000323	CbGpPWpGaD
Acitretin—Vomiting—Epirubicin—urinary bladder cancer	0.000116	0.000249	CcSEcCtD
Acitretin—Nausea—Methotrexate—urinary bladder cancer	0.000116	0.000248	CcSEcCtD
Acitretin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000116	0.000248	CcSEcCtD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000115	0.00032	CbGpPWpGaD
Acitretin—Rash—Epirubicin—urinary bladder cancer	0.000115	0.000247	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	0.000115	0.00032	CbGpPWpGaD
Acitretin—Dermatitis—Epirubicin—urinary bladder cancer	0.000115	0.000247	CcSEcCtD
Acitretin—Headache—Epirubicin—urinary bladder cancer	0.000115	0.000245	CcSEcCtD
Acitretin—ALB—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000114	0.000316	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000113	0.000313	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000112	0.000312	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000112	0.000312	CbGpPWpGaD
Acitretin—Dizziness—Doxorubicin—urinary bladder cancer	0.000112	0.00024	CcSEcCtD
Acitretin—RXRG—Gene Expression—ESR1—urinary bladder cancer	0.000111	0.000307	CbGpPWpGaD
Acitretin—RARG—Gene Expression—PPARG—urinary bladder cancer	0.00011	0.000307	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	0.00011	0.000305	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	0.000109	0.000303	CbGpPWpGaD
Acitretin—Nausea—Epirubicin—urinary bladder cancer	0.000109	0.000233	CcSEcCtD
Acitretin—RXRA—Metabolism—NAT2—urinary bladder cancer	0.000109	0.000302	CbGpPWpGaD
Acitretin—RARB—Gene Expression—ESR1—urinary bladder cancer	0.000109	0.000301	CbGpPWpGaD
Acitretin—Vomiting—Doxorubicin—urinary bladder cancer	0.000108	0.00023	CcSEcCtD
Acitretin—Rash—Doxorubicin—urinary bladder cancer	0.000107	0.000228	CcSEcCtD
Acitretin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000107	0.000228	CcSEcCtD
Acitretin—RXRA—Developmental Biology—CDK4—urinary bladder cancer	0.000106	0.000296	CbGpPWpGaD
Acitretin—Headache—Doxorubicin—urinary bladder cancer	0.000106	0.000227	CcSEcCtD
Acitretin—RARG—Gene Expression—CREBBP—urinary bladder cancer	0.000106	0.000294	CbGpPWpGaD
Acitretin—RBP1—Disease—CDKN1A—urinary bladder cancer	0.000104	0.00029	CbGpPWpGaD
Acitretin—RBP1—Disease—PTEN—urinary bladder cancer	0.000104	0.000289	CbGpPWpGaD
Acitretin—RARA—Gene Expression—ESR1—urinary bladder cancer	0.000104	0.000289	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—ESR1—urinary bladder cancer	0.000104	0.000289	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PPARG—urinary bladder cancer	0.000104	0.000288	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TP53—urinary bladder cancer	0.000103	0.000287	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000103	0.000285	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—SMC1A—urinary bladder cancer	0.000103	0.000285	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CREBBP—urinary bladder cancer	0.000102	0.000283	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—PPARG—urinary bladder cancer	0.000101	0.00028	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IGF1—urinary bladder cancer	0.000101	0.00028	CbGpPWpGaD
Acitretin—Nausea—Doxorubicin—urinary bladder cancer	0.000101	0.000215	CcSEcCtD
Acitretin—CYP26A1—Metabolism—CREBBP—urinary bladder cancer	9.95e-05	0.000276	CbGpPWpGaD
Acitretin—RBP1—Disease—EP300—urinary bladder cancer	9.93e-05	0.000276	CbGpPWpGaD
Acitretin—RARB—Gene Expression—PPARG—urinary bladder cancer	9.9e-05	0.000275	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—CREBBP—urinary bladder cancer	9.87e-05	0.000274	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—CREBBP—urinary bladder cancer	9.7e-05	0.000269	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	9.68e-05	0.000269	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—PPARG—urinary bladder cancer	9.67e-05	0.000269	CbGpPWpGaD
Acitretin—RBP1—Disease—SRC—urinary bladder cancer	9.65e-05	0.000268	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTZ1—urinary bladder cancer	9.54e-05	0.000265	CbGpPWpGaD
Acitretin—RARB—Gene Expression—CREBBP—urinary bladder cancer	9.51e-05	0.000264	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—PPARG—urinary bladder cancer	9.49e-05	0.000264	CbGpPWpGaD
Acitretin—RARA—Gene Expression—PPARG—urinary bladder cancer	9.49e-05	0.000264	CbGpPWpGaD
Acitretin—RXRA—Metabolism—RRM2—urinary bladder cancer	9.38e-05	0.00026	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—TNF—urinary bladder cancer	9.31e-05	0.000259	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—CREBBP—urinary bladder cancer	9.29e-05	0.000258	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—RHOA—urinary bladder cancer	9.23e-05	0.000256	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—CREBBP—urinary bladder cancer	9.12e-05	0.000253	CbGpPWpGaD
Acitretin—RARA—Gene Expression—CREBBP—urinary bladder cancer	9.12e-05	0.000253	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTO2—urinary bladder cancer	9.05e-05	0.000251	CbGpPWpGaD
Acitretin—ALB—Metabolism—NAT1—urinary bladder cancer	9.05e-05	0.000251	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—ESR2—urinary bladder cancer	8.94e-05	0.000248	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	8.9e-05	0.000247	CbGpPWpGaD
Acitretin—RXRA—Metabolism—HPGDS—urinary bladder cancer	8.69e-05	0.000241	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ENO2—urinary bladder cancer	8.69e-05	0.000241	CbGpPWpGaD
Acitretin—RBP1—Disease—MYC—urinary bladder cancer	8.65e-05	0.00024	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.64e-05	0.00024	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—ERBB2—urinary bladder cancer	8.55e-05	0.000237	CbGpPWpGaD
Acitretin—RBP1—Disease—EGFR—urinary bladder cancer	8.46e-05	0.000235	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTT1—urinary bladder cancer	8.43e-05	0.000234	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—RHOA—urinary bladder cancer	8.41e-05	0.000233	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.3e-05	0.00023	CbGpPWpGaD
Acitretin—ALB—Metabolism—UGT2B7—urinary bladder cancer	8.27e-05	0.00023	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTGS2—urinary bladder cancer	8.15e-05	0.000226	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CXCL8—urinary bladder cancer	8.11e-05	0.000225	CbGpPWpGaD
Acitretin—RBP1—Disease—KRAS—urinary bladder cancer	7.99e-05	0.000222	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	7.96e-05	0.000221	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.89e-05	0.000219	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—ERBB2—urinary bladder cancer	7.78e-05	0.000216	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL2—urinary bladder cancer	7.75e-05	0.000215	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	7.69e-05	0.000214	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CCND1—urinary bladder cancer	7.55e-05	0.00021	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP4B1—urinary bladder cancer	7.45e-05	0.000207	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MMP9—urinary bladder cancer	7.33e-05	0.000204	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CDKN1A—urinary bladder cancer	7.31e-05	0.000203	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	7.3e-05	0.000203	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PTEN—urinary bladder cancer	7.29e-05	0.000202	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTEN—urinary bladder cancer	7.11e-05	0.000197	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IFNA2—urinary bladder cancer	7.1e-05	0.000197	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC19A1—urinary bladder cancer	7.04e-05	0.000195	CbGpPWpGaD
Acitretin—RXRA—Metabolism—NQO1—urinary bladder cancer	7e-05	0.000194	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EP300—urinary bladder cancer	6.95e-05	0.000193	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—NCOR1—urinary bladder cancer	6.9e-05	0.000192	CbGpPWpGaD
Acitretin—ALB—Metabolism—PRSS3—urinary bladder cancer	6.86e-05	0.00019	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.79e-05	0.000189	CbGpPWpGaD
Acitretin—RBP1—Disease—HRAS—urinary bladder cancer	6.79e-05	0.000189	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—EP300—urinary bladder cancer	6.78e-05	0.000188	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SRC—urinary bladder cancer	6.76e-05	0.000188	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MMP9—urinary bladder cancer	6.67e-05	0.000185	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—ERCC2—urinary bladder cancer	6.49e-05	0.00018	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—EP300—urinary bladder cancer	6.33e-05	0.000176	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MYC—urinary bladder cancer	6.29e-05	0.000175	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—SRC—urinary bladder cancer	6.15e-05	0.000171	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	6.12e-05	0.00017	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MYC—urinary bladder cancer	6.06e-05	0.000168	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.93e-05	0.000165	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EGFR—urinary bladder cancer	5.93e-05	0.000165	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—MYC—urinary bladder cancer	5.86e-05	0.000163	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTP1—urinary bladder cancer	5.84e-05	0.000162	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MYC—urinary bladder cancer	5.76e-05	0.00016	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.65e-05	0.000157	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MYC—urinary bladder cancer	5.64e-05	0.000157	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KRAS—urinary bladder cancer	5.6e-05	0.000155	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.5e-05	0.000153	CbGpPWpGaD
Acitretin—ALB—Metabolism—TYMP—urinary bladder cancer	5.48e-05	0.000152	CbGpPWpGaD
Acitretin—RXRA—Metabolism—TYMS—urinary bladder cancer	5.43e-05	0.000151	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—ESR1—urinary bladder cancer	5.42e-05	0.000151	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MYC—urinary bladder cancer	5.41e-05	0.00015	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MYC—urinary bladder cancer	5.41e-05	0.00015	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—EGFR—urinary bladder cancer	5.39e-05	0.00015	CbGpPWpGaD
Acitretin—RXRA—Metabolism—NCOR1—urinary bladder cancer	5.37e-05	0.000149	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTM1—urinary bladder cancer	5.37e-05	0.000149	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	5.34e-05	0.000148	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.26e-05	0.000146	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GPX1—urinary bladder cancer	5.14e-05	0.000143	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—TNF—urinary bladder cancer	5.14e-05	0.000143	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—KRAS—urinary bladder cancer	5.09e-05	0.000141	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ERCC2—urinary bladder cancer	5.05e-05	0.00014	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PLAU—urinary bladder cancer	5.04e-05	0.00014	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—urinary bladder cancer	4.97e-05	0.000138	CbGpPWpGaD
Acitretin—ALB—Metabolism—NAT2—urinary bladder cancer	4.96e-05	0.000138	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PPARG—urinary bladder cancer	4.95e-05	0.000137	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—HRAS—urinary bladder cancer	4.76e-05	0.000132	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—CREBBP—urinary bladder cancer	4.75e-05	0.000132	CbGpPWpGaD
Acitretin—RXRA—Metabolism—MTHFR—urinary bladder cancer	4.74e-05	0.000132	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—HRAS—urinary bladder cancer	4.33e-05	0.00012	CbGpPWpGaD
Acitretin—ALB—Metabolism—RRM2—urinary bladder cancer	4.28e-05	0.000119	CbGpPWpGaD
Acitretin—ALB—Hemostasis—CREBBP—urinary bladder cancer	4.16e-05	0.000115	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IGF1—urinary bladder cancer	4.11e-05	0.000114	CbGpPWpGaD
Acitretin—ALB—Metabolism—HPGDS—urinary bladder cancer	3.96e-05	0.00011	CbGpPWpGaD
Acitretin—ALB—Metabolism—ENO2—urinary bladder cancer	3.96e-05	0.00011	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.94e-05	0.000109	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PPARG—urinary bladder cancer	3.85e-05	0.000107	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTT1—urinary bladder cancer	3.84e-05	0.000107	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.78e-05	0.000105	CbGpPWpGaD
Acitretin—ALB—Hemostasis—RHOA—urinary bladder cancer	3.76e-05	0.000104	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CREBBP—urinary bladder cancer	3.7e-05	0.000103	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.6e-05	9.99e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—NQO1—urinary bladder cancer	3.19e-05	8.87e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IL2—urinary bladder cancer	3.16e-05	8.76e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.1e-05	8.61e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTGS2—urinary bladder cancer	3.03e-05	8.4e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—EP300—urinary bladder cancer	2.83e-05	7.86e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MYC—urinary bladder cancer	2.82e-05	7.83e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SRC—urinary bladder cancer	2.75e-05	7.64e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.7e-05	7.5e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTP1—urinary bladder cancer	2.66e-05	7.4e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTEN—urinary bladder cancer	2.64e-05	7.33e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.58e-05	7.16e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—EP300—urinary bladder cancer	2.52e-05	6.99e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—TYMS—urinary bladder cancer	2.48e-05	6.88e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—NCOR1—urinary bladder cancer	2.45e-05	6.8e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTM1—urinary bladder cancer	2.45e-05	6.8e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GPX1—urinary bladder cancer	2.34e-05	6.51e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—ERCC2—urinary bladder cancer	2.3e-05	6.39e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—KRAS—urinary bladder cancer	2.28e-05	6.33e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—MTHFR—urinary bladder cancer	2.16e-05	6.01e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—urinary bladder cancer	2.03e-05	5.63e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HRAS—urinary bladder cancer	1.94e-05	5.38e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PPARG—urinary bladder cancer	1.75e-05	4.87e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CREBBP—urinary bladder cancer	1.69e-05	4.68e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTGS2—urinary bladder cancer	1.38e-05	3.83e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTEN—urinary bladder cancer	1.2e-05	3.34e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—EP300—urinary bladder cancer	1.15e-05	3.19e-05	CbGpPWpGaD
